Genetic or pharmacological Sirt1 inhibition can induce insulin resistance (IR) [72], and genetic Sirt1 variations have been associated with human energy expenditure and obesity [73,74,75]. Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.